ALISERTIB for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 6 adverse event reports in the FDA FAERS database where ALISERTIB was used for Neoplasm malignant.

Most Reported Side Effects for ALISERTIB

Side Effect	Reports	%	Deaths	Hosp.
Neutropenia	16	19.1%	2	1
Dehydration	12	14.3%	1	4
Hyponatraemia	10	11.9%	0	2
Malignant neoplasm progression	10	11.9%	1	0
Toxicity to various agents	10	11.9%	0	0
Anaemia	9	10.7%	3	2
Leukopenia	9	10.7%	0	1
Lymphopenia	9	10.7%	0	2
Mucosal inflammation	9	10.7%	0	2
Febrile neutropenia	8	9.5%	1	2
Fatigue	7	8.3%	2	3
Vomiting	7	8.3%	1	1
Diarrhoea	6	7.1%	1	1
Thrombocytopenia	6	7.1%	2	1
Drug ineffective	5	6.0%	0	0